pharmaphorum

DECEMBER 21, 2021

Additionally, the work being done within Rare Disease networks, formed of specialty sites, pharma companies, CROs, researchers, and other stakeholders, can all benefit from the value generated by real world genomic data, as outlined by panellist Dr Joanne Hackett, Head of Genomic and Precision medicine at IQVIA.

Development 91

Development Genome Genomics Drugs 91

Cloudbyz

MAY 19, 2021

Moreover, 12% of industrial clinical pipeline products and at least 16% of preclinical pipeline products consist of CGT. The primary drivers for growth include increasing cancer and genetic cases and predicated applicability of CGT as a treatment.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

Drug Discovery World

OCTOBER 16, 2023

Scotland Saleko adds that Scotland, as a devolved nation, has an innovative NHS system that has propelled it to become a key site for translational medical research. From the Beatson Institute for Cancer Research in Glasgow, to Edinburgh Drug Discovery in the University of Edinburgh’s Institute for Genetics and Cancer (IGC).

Drugs 75

Drugs Life Science Gene Therapy Genome 75

Drug Discovery World

JANUARY 24, 2023

In the near term, as we’ve seen in oncology, we will benefit from new access to important genetic and biological information to not only select patients who will best respond to test therapies, but also more accurately measure the effect of a test therapy in a disease.” Quantifying the use of connected digital products in clinical research.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

The Pharma Data

DECEMBER 17, 2020

Most recently, Cadavid served as senior vice president and Head of Clinical Development at Fulcrum Therapeutics where he led the development of multiple small molecules for the treatment of genetically defined rare diseases. AB2 Bio – Swiss pharma company AB2 Bio Ltd.

Development 52

Development Gene Therapy Engineer Life Science 52

pharmaphorum

NOVEMBER 27, 2022

A group representing pharma companies selling precision therapies for cancer has called for a change to the way genomic testing is done in Scotland, to make sure patients get access to targeted drugs. Let’s lead by doing things – by making decisions to lead.”

Genome 84

Genome Genomics Genetics Medicine 84

pharmaphorum

MAY 26, 2022

Inadequate clinical trial representations of all populations can therefore leave underrepresented groups vulnerable due to the lack of subgroup-specific data. While many pharma companies are actively working on initiatives to improve diversity in clinical trials, we still have a long way to go.

Clinical Trials 131

Clinical Trials Clinical Trials Trials Medicine 131

pharmaphorum

SEPTEMBER 1, 2020

Likewise, the 1964 Declaration of Helsinki put greater ethical structures on clinical research, clearly cementing the difference between production of scientific prescription medicines and other chemicals. This knowledge of genetics and the underlying cause of many diseases, including cancer, has resulted in powerful new drugs.

Medicine 145

Medicine Insulin Pharmacy Drugs 145

XTalks

OCTOBER 1, 2020

Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. Working on finding therapies for genetic diseases at NeuBase, Dr. Sooter says, “Everyday, we get up and that’s our goal and it really drives everyone.

Scientist 52

Scientist In-Vitro Research Life Science 52

Pharmaceutical Technology

APRIL 12, 2023

However, critics like Jarrod Bailey, science director at Animal Free Research UK, say a greater shift towards non-animal models needs to happen sooner rather than later. Already, [non-animal models] are assisting greatly in the repurposing of existing drugs,” he says. “We

Regulation 245

Regulation Vaccination Vaccine Medicine 245